Back to LCT Homepage Targeting Huntington's Disease, Stroke, Type 1 Diabetes and Haemophilia
Living Cell Technologies
LCT - Living Cell Technologies
News updates: Subscribe
Unsubscribe


June 5, 2008
LCT Expands Diabetes Clinical Trial
June 3, 2008
LCT Lists on International OTCQX
May 21, 2008
LCT interviewed by New Zealand TV program, Close Up
May 12, 2008
LCT presents encapsulation technology at conference
May 8, 2008
LCT features on Channel Ten News
May 8, 2008
LCT prepares to list on international OTCQX
 

About ADRs

American Depositary Receipts (ADRs) are a negotiable instrument issued by a US depositary bank evidencing ownership interests in shares in a non-US company. Each ADR evidences American Depositary Shares (ADSs), representing a specific number of underlying shares on deposit with a custodian in the issuer's home market. ADRs are quoted and traded in US dollars in the US securities market, and the associated dividends are paid to investors in US dollars. ADRs facilitate the purchase, holding and sale of non-US securities by US investors and provide a corporate finance vehicle for non-US issuers. These securities are often known as simply DRs.


How to purchase ADRs

ADR Frequently Asked Questions

LCT - Living Cell Technologies
What is xenotransplantation?
The use of living animal cells, tissues or organs in human therapeutics. >more

What is DiabeCell?
DiabeCell is a porcine pancreatic cell product for the treatment of insulin-dependent diabetes. >more

What is NeurotrophinCell?
A choroid plexus (brain) cell product with the potential to treat diseases of the nervous system such as Huntington's disease and stroke. >more

What is LCT's encapsulation technology?
The living cells are covered in a seaweed-derived coating (alginate encapsulation) to form capsules which eliminate the
need for toxic immunosuppressant drugs and allow the release of beneficial factors.
>more
   
graphic design and website design - PDF Communications Ltd